Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report

Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report

A 60-year-old woman suffering from multiple myeloma (MM) was treated with zoledronic acid (bisphosphonate), dexamethasone (corticosteroid), bortezomib (a chemotherapeutic agent), and lenalidomide (thalidomide analog) for about a year and with lenalidomide alone as maintenance therapy for almost two...

Full description

Bibliographic Details
Main Authors:	Mario Caggiano, Federica Di Spirito, Alfonso Acerra, Marzio Galdi, Laura Sisalli
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Dentistry Journal
Subjects:	oral cavity oral lesion lenalidomide adverse event osteonecrosis of the jaws adverse drug reaction
Online Access:	https://www.mdpi.com/2304-6767/11/4/104

Similar Items

Idiopathic Exposed Bone Lesions of the Jaw
by: Božana Lončar Brzak, et al.
Published: (2019-06-01)

Are medication-induced salivary changes the culprit of osteonecrosis of the jaw? A systematic review
by: Isti Rahayu Suryani, et al.
Published: (2023-08-01)

Management of Medication-Related Osteonecrosis of the Jaw with Photobiomodulation and Minimal Surgical Intervention
by: Marwan El Mobadder, et al.
Published: (2023-05-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
by: Seung-Hun Lee, et al.
Published: (2021-07-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

Medication-related osteonecrosis of the jaw in a patient with multiple myeloma
by: Nupur Bhardwaj, et al.
Published: (2015-01-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Evaluation of the qualitative and quantitative composition of or al microbiota in patients with medial osteonecrosis of the jaw
by: T. P. Ivanyushko, et al.
Published: (2019-08-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Oral health, dental treatment, and medication related osteonecrosis of the jaw in multiple myeloma – a longitudinal cohort study
by: Richard Olofsson, et al.
Published: (2024-02-01)

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Bisphosphonate related osteonecrosis of jaw: A case report
by: Waquar Ahmed, et al.
Published: (2017-01-01)

Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression
by: Ashraf Z. Badros, et al.
Published: (2021-06-01)

Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate
by: Hiroko Okawa, et al.
Published: (2022-08-01)

Medication-related osteonecrosis of jaw and rheumatoid arthritis: Revisiting the concepts
by: Adity Bansal, et al.
Published: (2021-01-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01)

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)

Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study
by: Heon-Young Kim, et al.
Published: (2024-02-01)

Metastatic pancreatic cancer mimicking medication related osteonecrosis of the jaw—A rare clinical presentation
by: Sandeep Gurav, et al.
Published: (2023-12-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Dentists’ Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia
by: Sven Bival, et al.
Published: (2023-01-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Clinical study of bisphosphonate⁃related osteonecrosis of the jaws
by: WU Yu⁃ling, et al.
Published: (2017-01-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Osteonecrosis of jaw bones: A complication of severe dengue
by: S M Ravi Prakash, et al.
Published: (2018-01-01)

Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
by: Hardeep S. Ahdi, et al.
Published: (2023-03-01)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Letter to the editor regarding “Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw”
by: E. Nastro Siniscalchi, et al.
Published: (2020-11-01)